Literature DB >> 17941597

Canine subclinical prostatic disease: histological prevalence and validity of digital rectal examination as a screening test.

S Mukaratirwa1, T Chitura.   

Abstract

The present study investigated the histological prevalence of subclinical prostatic disease in a canine mixed-breed population. The reliability of digital rectal examination (DRE) as a screening test for subclinical prostatic disease was also evaluated. DRE was performed on 500 male dogs (age range 1 to 21 years) before the dogs died of diseases not related to the prostate. Necropsies of these dogs were performed and prostates were collected for histological evaluation. The overall prevalence of subclinical prostatic disease was 75.6%. The most prevalent subclinical prostatic diseases were benign prostatic hyperplasia (BPH) (44.8%), prostatitis (23.6%) and prostatic neoplasia (3.6%). The prevalence of subclinical BPH and prostatic neoplasia increased with age but that of prostatitis was not influenced by age. The prevalence of subclinical BPH and prostatitis were higher in intact than castrated dogs. DRE had a high specificity (75%) and positive predictive value (87%), but a low sensitivity (53%) and negative predictive value (34%).

Entities:  

Mesh:

Year:  2007        PMID: 17941597     DOI: 10.4102/jsava.v78i2.292

Source DB:  PubMed          Journal:  J S Afr Vet Assoc        ISSN: 1019-9128            Impact factor:   1.474


  4 in total

1.  A retrospective review of canine benign prostatic hyperplasia with and without prostatitis.

Authors:  Hannah Ruetten; Marlyse Wehber; Mary Murphy; Clara Cole; Simran Sandhu; Steven Oakes; Dale Bjorling; Kenneth Waller; Katrina Viviano; Chad Vezina
Journal:  Clin Theriogenology       Date:  2021-12

Review 2.  A Review on Canine and Feline Prostate Pathology.

Authors:  Chiara Palmieri; Carlos Eduardo Fonseca-Alves; Renee Laufer-Amorim
Journal:  Front Vet Sci       Date:  2022-05-26

3.  Evaluation of biomarker canine-prostate specific arginine esterase (CPSE) for the diagnosis of benign prostatic hyperplasia.

Authors:  Dora Pinheiro; João Machado; Carlos Viegas; Cláudia Baptista; Estela Bastos; Joana Magalhães; Maria A Pires; Luís Cardoso; Ana Martins-Bessa
Journal:  BMC Vet Res       Date:  2017-03-23       Impact factor: 2.741

4.  Hemato-biochemical alterations and urinalysis in dogs suffering from benign prostatic hyperplasia.

Authors:  M R Das; R C Patra; R K Das; P K Rath; B P Mishra
Journal:  Vet World       Date:  2017-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.